Conference Objectives
To explore how new tools and mechanisms of responsible innovation can help open pathways for public purposes such as energy and food security, climate change mitigation and systems transitions, while building public trust in the STI system, and preventing or correcting potential negative effects;
To pool practical ideas, experiences and knowledge to anticipate longer-term impacts of emerging technologies and support capacities to promote, steer and cope with socio-technical change;
To explore what kinds of multilateral approaches might be necessary for promoting responsible technology and inclusive transitions.
Contact: David Winickoff (STI/STP)
BIOTECHNOLOGY STATISTICS The OECD Key Biotech Indicators (KBI) and the OECD Key Nanotech Indicators (KNI) were updated in October 2020. Time series are presented for a select number of indicators. Visit the websites to see the latest interactive visualisations! Biotechnology R&D expenditures in the business sector as a percentage of Business Enterprise R&D, latest available year Percentages % 35 30
25
latest
20 15 10 5 0
32.4 29.7 26.9 14.9 14.1 12.6 9.1 8.8 8.7 6.8 5.3 4.6 3.7
The KBI are available at: oe.cd/kbi and the KNI data are available at: oe.cd/kni. Contact:
Brigitte van Beuzekom (STI/STP)
16
